Position
Chief Executive Officer
Company
Grey Wolf Therapeutics
Description
Greywolf Therapeutics has appointed Darlene Deptula-Hicks as Chief Financial Officer. Ms. Deptula-Hicks, an accomplished biotech and healthcare executive, brings over 30 years of corporate finance, capital markets, M&A, accounting and investor relations experience within publicly listed US companies and private healthcare and biotech companies.
Quick answer
Greywolf Therapeutics Appoints Darlene Deptula-Hicks as Chief Financial Officer (November 14, 2024). Grey Wolf Therapeutics is based in Milton, Oxfordshire, United Kingdom.
- What did Grey Wolf Therapeutics announce on November 14, 2024?
- Greywolf Therapeutics has appointed Darlene Deptula-Hicks as Chief Financial Officer. Ms. Deptula-Hicks, an accomplished biotech and healthcare executive, brings over 30 years of corporate finance, capital markets, M&A, accounting and investor relations experience within publicly listed US companies and private healthcare and biotech companies.
- What does Grey Wolf Therapeutics do?
- Grey Wolf Therapeutics is a UK-based drug discovery biotechnology company focused on immuno-oncology and founded by experienced industry professionals Tom McCarthy (Executive Chairman), former President and CEO of...
- Where is Grey Wolf Therapeutics based?
- Grey Wolf Therapeutics is based in Milton, Oxfordshire, United Kingdom.
- Which similar companies made leadership changes around the same time?
- ALX Oncology (November 14, 2024), Diakonos Oncology (November 18, 2024), NRx Pharmaceuticals (November 18, 2024) and Georgiamune (November 19, 2024) also announced leadership changes within 45 days of Grey Wolf Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Medical and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- ALX Oncology Appoints Alan Sandler, M.D., as Chief Medical Officer (November 14, 2024)
- Diakonos Oncology Appoints Laura Aguilar, M.D., Ph.D. as Chief Medical Officer (November 18, 2024)
- NRx Pharmaceuticals Appoints Michael Abrams as Chief Financial Officer (November 18, 2024)
- Georgiamune Inc. Appoints Mark Avagliano as Chief Business Officer (November 19, 2024)
- neurocare Group AG Appoints Kevin Reeder as Chief Financial Officer (November 21, 2024)
- Faeth Therapeutics Appoints Dr. Stephen Hahn as Chief Medical Executive and Dr. Jayson Dallas as Chief Executive Officer (November 22, 2024)
Who to call at Grey Wolf Therapeutics, and when
A new leader at Grey Wolf Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Grey Wolf Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Grey Wolf Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Grey Wolf Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Grey Wolf Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Grey Wolf Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.